Paradigm shift in the management of mild asthma: Focus toward a patient centered approach

Asthma affects nearly 340 million people worldwide and over 50% of patients have mild asthma. The goals of treatment are to improve day-to-day asthma symptom control and to reduce the risk of exacerbations requiring systemic corticosteroids, and emergency department visits and hospitalizations. Airway inflammation and smooth muscle hyperresponsiveness are the pathophysiological hallmarks of asthma, but until recently, mild asthma treatment …